What Does the Historical and Current Pharmaceutical Pellets Market Size Trend Indicate?
The pharmaceutical pellets market has seen considerable growth due to a variety of factors.
•In the past few years, the pharmaceutical pellets market has witnessed a swift expansion. The market is projected to increase from $1.82 billion in 2024 to $2.03 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%.
The hike in the historic period is due to factors like improving patient compliance, the increased use of oral dosage forms, pharmaceutical research initiatives, efforts for taste-masking and stability, and an uptick in regulatory approvals and patents.
How Will the Pharmaceutical Pellets Market Size Evolve over the Forecast Period?
The pharmaceutical pellets market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the pharmaceutical pellets market is poised for substantial expansion, propelling up to $3.16 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%.
The surge during the forecast period is likely to be stimulated by higher demand for pediatric dosage forms, multi-particulate dosage forms, and advancement of combination therapy dosage forms, alongside continuous manufacturing improvements and focus on geriatric dosage forms. Noteworthy trends in the forecast period encompass integration of 3d printing technologies, their utilization in personalized nutrition alongside smart coatings for real-time monitoring, orally disintegrating pellets, and the movement towards biodegradable and eco-friendly pellets.
What Are The Core Factors Supporting Growth In The Pharmaceutical Pellets Market?
Growing incidences of chronic illnesses are anticipated to fuel the expansion of the pharmaceutical pellets market. Chronic ailments are characterized as conditions that endure for more than a year, requiring ongoing medical attention, impeding daily routine, or both. Pharmaceutical pellets usage could be advantageous in managing these chronic diseases as they minimize digestive issues and facilitate better drug absorption. For example, the National Center for Biotechnology Information (NCBI), an American National Library of Medicine entity, indicated in January 2023 that by 2050, there will be a leap of 99.5% in the population aged 50 years and above living with at least one chronic disease. The figures are projected to escalate from 71.522 million in 2020 to 142.66 million. Thus, the rising trend of chronic diseases propels the expansion of the pharmaceutical pellets market.
What Are The Major Segments Within The Global Pharmaceutical Pellets Market?
The pharmaceutical pellets market covered in this report is segmented –
1) By Technology: Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution And Suspension Layering, Spray Congealing, Spray Drying
2) By Mechanism Of Action: Diffusion, Erosion, Osmosis
3) By Technique: Direct, Melt, Wet, Dry
4) By End-User: Pharmaceutical, Nutraceutical
Subsegments:
1) By Extrusion: Melt Extrusion, Solvent-Based Extrusion
2) By Fluid Bed Granulation: Top-Spray Granulation, Bottom-Spray Granulation
3) By Dry Powder Layering: Powder Layering On Inert Cores, Coating Techniques
4) By Solution And Suspension Layering: Solution Layering, Suspension Layering
5) By Spray Congealing: Hot Melt Spraying, Cooling Methods
6) By Spray Drying: Single-Stage Spray Drying, Multi-Stage Spray Drying
Pre-Book The Pharmaceutical Pellets Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Pharmaceutical Pellets Market?
Product innovation is increasingly becoming an essential trend in the pharmaceutical pellets industry. Firms in this market are centering their efforts on creating novel products to maintain their market stance. For instance, in May 2024, US-based engineering company, Schedio SA, rolled out the High Potent Pilot Particle Engineering Platform. This state-of-the-art platform can support up to 465 configurations and is compatible with spray dryers and jet mills, targeting the improvement of particle engineering for high-potency compounds in the pharmaceutical sector. The platform offers high containment and intuitive controls focused on ensuring safety, accuracy, and adherence to regulations in pharmaceutical production processes.
Who Are the Key Players in the Pharmaceutical Pellets Market?
Major companies operating in the pharmaceutical pellets market include:
• Abbott Laboratories
• Takeda
• Boehringer Ingelheim
• Teva Pharmaceutical Industries Ltd.
• Eisai Co. Ltd.
• Colorcon Inc.
• Nordic Sugar AB
• Pfizer
• Merck & Co.
• Manus Aktteva Biopharma LLP
• Thexa Pharma (P) Limited
• Avanscure Lifesciences Private Limited
• MB Sugars & Pharmaceuticals Limited
• CIL Laboratories Pvt Ltd
• Sainor Pharma Pvt Ltd
• Umang Pharmatech Pvt Ltd
• Nami Lifesciences Pvt Ltd
• Lograns Pharma Private Limited
• Rainbow Health Care Products
• Chemit Laboratories
• Concord Drugs Limited
• Pharmaceuticals Private Limited
• Nanjing Joyfulchem ??Co. Ltd.
• Praful International Corporation
• Pellets Pharma Limited
• A B Enterprises
• Vision Pharmacoat Pvt Ltd
• Spansules Pharma
• Ravoos Laboratories Ltd
What Is The Most Dominant Region In The Pharmaceutical Pellets Market?
North America was the largest region in the pharmaceutical pellets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical pellets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
